➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Dow
Harvard Business School
Medtronic
Express Scripts

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Acarbose - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Prices for acarbose

See drug prices for acarbose

Recent Clinical Trials for acarbose

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Clinical Trial Consultants ABPhase 1/Phase 2
Empros Pharma ABPhase 1/Phase 2
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolN/A

See all acarbose clinical trials

Pharmacology for acarbose
Medical Subject Heading (MeSH) Categories for acarbose
Paragraph IV (Patent) Challenges for ACARBOSE
Tradename Dosage Ingredient NDA Submissiondate
PRECOSE TABLET;ORAL acarbose 020482 2005-03-22

US Patents and Regulatory Information for acarbose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan ACARBOSE acarbose TABLET;ORAL 091053-002 Jan 6, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
Virtus Pharm ACARBOSE acarbose TABLET;ORAL 091343-003 Oct 17, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Emcure Pharms Ltd ACARBOSE acarbose TABLET;ORAL 202271-002 Feb 7, 2012 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs ACARBOSE acarbose TABLET;ORAL 077532-003 May 7, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Virtus Pharm ACARBOSE acarbose TABLET;ORAL 091343-001 Oct 17, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Strides Pharma ACARBOSE acarbose TABLET;ORAL 090912-002 Jul 27, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Watson Labs ACARBOSE acarbose TABLET;ORAL 077532-002 May 7, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for acarbose

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-004 May 29, 1997   Start Trial   Start Trial
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-002 Sep 6, 1995   Start Trial   Start Trial
Bayer Hlthcare PRECOSE acarbose TABLET;ORAL 020482-001 Sep 6, 1995   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Moodys
Boehringer Ingelheim
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.